A new method of genome manipulation can rapidly engineer RNA viruses through precise cleavage and repair, with potential applications for antiviral therapeutics, vaccines, and screening of mutations.
The new recombinant technology enables specific deletions and insertions to the RNA of viruses. This is done through a combination of sequence-specific RNA cleavage by CRISPR ribonucleases and programmable RNA repair.